5-tert-butyl 3-methyl 6-[(benzylthio)methyl]-6,7-dihydro[1,2,3]triazolo[1,5-a]pyrazine-3,5(4H)-dicarboxylate, 5mg

6-Bromo-[1,2,4]triazolo[4,3-a]pyrazine, 98%, 10g

2-Methyl-2H-indazole-4-carboxylic acid, 95.0%, 250mg

1-((2-(2,6-DIOXOPIPERIDIN-3-YL)-1,3-DIOXOISOINDOLIN-4-YL)AMINO)-3,6,9,12,15,18-HEXAOXAHENICOSAN-21-OIC ACID, 95%, 50mg

5-Bromo-3-(trifluoromethyl)-1H-pyrrolo[2,3-b]pyridine, 95.0%, 5g

[(4,6-dimethyl-3-pyridinyl)methyl]amine dihydrochloride, 95.0%, 100mg

Reaction vials ROTILABO®, 1.5 ml, colourless, Non-sterile, 500 Piece(s)

4-Acetylthiazole, 98.0%, 1g

Bicyclo[4.2.0]octa-1,3,5-trien-7-one, 95.0%, 1g

Isopropyl m-tolyl sulphide, 1g

(2-Amino-5-chloro-3-methylphenyl)methanol, 98%, 1g

2-Amino-4,6-dichloro-pyrimidine-5-carbaldehyde, 96.0%, 5g

1-(Benzyloxy)-3-fluorobenzene, 95.0%, 25g